Please wait

Exhibit 107

Calculation of Filing Fee Tables

424(b)(5)

(Form Type)

Cytokinetics, Incorporated

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                 
     Security
Type		   Security
Class Title		   Fee
Calculation or
Carry
Forward Rule		   Amount
Registered		   Proposed
Maximum
Offering
Price Per
Share		  

Maximum
Aggregate
Offering

Price(1)

  

Fee

Rate

   Amount of
Registration Fee
 
Newly Registered Securities
                 
Fees to Be Paid   Equity   Common stock, par value $0.001 per share   457(o) and 457(r)   —   —   $300,000,000   $0.00011020   $33,060
           
    Total Offering Amounts     $300,000,000     $33,060
           
    Total Fees Previously Paid         —
           
    Total Fee Offsets         $6,490
           
    Net Fees Due               $26,570

Table 2: Fee Offset Claims and Sources

 

                       
    

Registrant

or Filer

Name

  

Form or
Filing

Type

  

File

Number

  

Initial
Filing

Date

  

Filing

Date

   Fee Offset
Claimed		   Security
Type
Associated
with Fee
Offset
Claimed		   Security
Title
Associated
with Fee
Offset
Claimed		   Unsold
Securities
Associated
with Fee
Offset
Claimed		   Unsold
Aggregated
Offering
Amount
Associated with
Fee Offset
Claimed		   Fee Paid with
Fee Offset
Source
 
Rule 457(p)
                       

Fee Offset Claims

   Cytokinetics, Incorporated   424(b)(5)   333-234537   5/8/2020     $6,490   Equity   Common Stock, par value $0.001 per share   —   $50,000,000    
                       
Fee Offset Sources   Cytokinetics, Incorporated   424(b)(5)   333-234537       5/8/2020       Equity   Common Stock, par value $0.001 per share           $6,490(2)

 

(1)

The registration fee is calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”), based on the proposed maximum aggregate offering price, and Rule 457(r) under the Securities Act. In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant initially deferred payment of all of the registration fee for Registration Statement No. 333-268483.

(2)

On May 8, 2020, the registrant filed a prospectus supplement (the “2020 Prospectus Supplement”) to the prospectus included in its Registration Statement on Form S-3 (Registration Statement No. 333-234537) (the “2019 Registration Statement”) and concurrently submitted a fee of $6,490. The 2020 Prospectus Supplement related to the registrant’s offer and sale from time to time of shares of the registrant’s common stock, par value $0.001 per share, having an aggregate gross sales price of up to $50,000,000 from time to time under the at-the-market program. As of the date of this prospectus supplement, $50,000,000 remains unsold under the at-the-market program. The 2019 Registration Statement has expired and the offering that included the unsold securities under the 2020 Prospectus Supplement has been terminated. Pursuant to Rule 457(p) under the Securities Act, a registration fee credit of $6,490 is available to offset the current registration fee.